Stock Events

Stock Events

Nanoform Finland 

€0.9430
18
-€0.02-1.77% 15:24 Today

Statistics

Day High
0.97
Day Low
0.94
52W High
1.382
52W Low
0.377
Volume
39,281
Avg. Volume
76,980
Mkt Cap
80.87M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

11NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-0.07
-0.05
-0.04
-0.02
Expected EPS
-0.02990347668
Actual EPS
N/A

Financials

-504.74%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
3.55MRevenue
-17.9MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow NANOFH.HE. It's not an investment recommendation.
Nordea Bank Abp
6
NDA-FI.HE
NVIDIA
5
NVDA
Microsoft
4
MSFT
Amazon
4
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Merck
MRK
Mkt Cap366B
Merck KGaA operates in the healthcare sector, offering a range of specialty chemicals, materials, and services for pharmaceutical manufacturing that overlap with Nanoform's nanoparticle engineering for drug development.
DuPont de Nemours
DD
Mkt Cap18.5B
DuPont de Nemours, Inc. offers a variety of materials and solutions for the pharmaceutical industry, including drug delivery technologies that compete with Nanoform's offerings.
Pfizer
PFE
Mkt Cap159.36B
Pfizer Inc., as a large pharmaceutical company, invests in drug delivery and formulation technologies, potentially competing with Nanoform's innovative nanoparticle solutions.
Astrazeneca
AZN.LSE
Mkt Cap199.04B
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its pharmaceutical division Janssen, develops and manufactures drugs that may utilize technologies competing with Nanoform's nanoparticle engineering.
GSK
GSK.LSE
Mkt Cap78.89B
Novo Nordisk
NVO
Mkt Cap201.64B
Novo Nordisk A/S focuses on drug delivery systems for its diabetes and obesity care products, which could compete with Nanoform's nanoparticle formulation technologies.

About

Helsinki, Finland-based Nanoform Finland Oyj provides advanced nanotechnology and drug particle engineering solutions for the pharmaceutical sector across Europe and the United States. The company specializes in the production of nanoparticles, utilizing its exclusive "controlled expansion of supercritical solutions" technology, which aids its clients in their development processes. Nanoform was established in 2008.
Show more...
CEO
Edward Olof Haeggstrom
Employees
171
Country
Finland
ISIN
FI4000330972
WKN
000A2P5N7

Listings

ST
SE
NANOFS.ST
STU
DE
4YL.STU
MU
DE
4YL.MU
HE
FI
NANOFH.HE

0 Comments

Share your thoughts

FAQ

What is Nanoform Finland stock price today?▼
The current price of NANOFH.HE is €0.94 EUR — it has decreased by -1.77% in the past 24 hours. Watch Nanoform Finland stock price performance more closely on the chart.
What is Nanoform Finland stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Helsinki Exchange exchange Nanoform Finland stocks are traded under the ticker NANOFH.HE.
Is Nanoform Finland stock price growing?▼
NANOFH.HE stock has fallen by -6.45% compared to the previous week, the month change is a +2.61% rise, over the last year Nanoform Finland has showed a +13.75% increase.
What is Nanoform Finland market cap?▼
Today Nanoform Finland has the market capitalization of 80.87M
When is the next Nanoform Finland earnings date?▼
Nanoform Finland is going to release the next earnings report on November 11, 2026.
What were Nanoform Finland earnings last quarter?▼
NANOFH.HE earnings for the last quarter are -0.04 EUR per share, whereas the estimation was -0.04 EUR resulting in a +0% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Nanoform Finland revenue for the last year?▼
Nanoform Finland revenue for the last year amounts to 3.55M EUR.
What is Nanoform Finland net income for the last year?▼
NANOFH.HE net income for the last year is -17.9M EUR.
How many employees does Nanoform Finland have?▼
As of September 04, 2026, the company has 171 employees.
In which sector is Nanoform Finland located?▼
Nanoform Finland operates in the Health & Wellness sector.
When did Nanoform Finland complete a stock split?▼
Nanoform Finland has not had any recent stock splits.
Where is Nanoform Finland headquartered?▼
Nanoform Finland is headquartered in Helsinki, Finland.